Evidence map›Paper›PMID 42717421›Full record

ArticleJournal of mass spectrometry : JMS2026

Detailed Chemical Composition Characterization and Multicomponent Quality Control of Cyclocarya paliurus by Combining UPLC-Q-Orbitrap MS, GC-MS, and GC-IMS.

Jun Zhu, Xinggui Zhang, Yanhua Qin, Fan Cao, Zhiren Yao, Siyang Fang, Zhiqi Yin

Abstract read
In one paragraph

Article in Journal of mass spectrometry : JMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jun ZhuDepartment of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
Xinggui ZhangDepartment of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
Yanhua QinChina Tobacco Jiangsu Industrial Co. LTD, Nanjing, China.
Fan CaoChina Tobacco Jiangsu Industrial Co. LTD, Nanjing, China.
Zhiren YaoDepartment of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
Siyang FangDepartment of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
Zhiqi YinDepartment of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.ORCID https://orcid.org/0000-0001-8989-6760

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclocarya paliurus (C. paliurus) is a novel food resource with traditional medicinal properties, including heat-clearing, detumescence, and analgesia. It has exhibited significant therapeutic effects in the treatment of metabolic diseases such as hyperglycemia, hyperlipidemia, and hypertension, making it a crucial ingredient in pharmaceutical and health food formulations. However, quality control studies focusing on the multi-component pharmacologically active substances in C. paliurus remain limited. Here, this study employed ultra-performance liquid chromatography-quadrupole-Orbitrap mass spectrometry (UPLC-Q-Orbitrap-MS), gas chromatography-mass spectrometry (GC-MS), and gas chromatography-ion mobility spectrometry (GC-IMS) technologies to profoundly characterize major pharmacologically active substances and quantitatively assess the quality of C. paliurus. A total of 88 compounds were identified from C. paliurus by UPLC-Q-Orbitrap MS, whereas 129 volatile constituents were detected through GC-MS and GC-IMS analysis. Furthermore, an adjusted parallel reaction monitoring (PRM) method was developed and validated for the quantification of eight key effective components of different types in C. paliurus, which were selected as benchmark substances for quality evaluation. In summary, this work offers a universally applicable method for identifying global metabolites and determining the multicomponent composition of complex in traditional Chinese medicine ingredients, providing a pragmatic workflow for assessing the quality and consistency.

Indexed as

Drugs, Chinese HerbalGas Chromatography-Mass SpectrometryJuglandaceaeChromatography, High Pressure LiquidIon Mobility SpectrometryLiquid Chromatography-Mass SpectrometryQuality ControlVolatile Organic CompoundsDrugs, Chinese HerbalVolatile Organic CompoundsCyclocarya paliurusGC–IMSGC–MSparallel reaction monitoringquality controlUPLC‐Q‐Orbitrap MS

Identifiers

PMID42717421
PMCPMC13558789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.